The overexpression and abnormal localization of ezrin, the founding member of the ezrin-radixin-moesin (ERM) family of membrane cytoskeletal crosslinkers [1], has been associated with positive LN status, metastasis, and poor outcome in various human cancers including breast [2]-[5]. This evidence concerns the gene EZR and cancer.